JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 39 No. 6 938-944
© 1998 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tadamura, E.
Right arrow Articles by Konishi, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tadamura, E.
Right arrow Articles by Konishi, J.

First-Pass Radionuclide Angiography Using Iodine 123 Myocardial Tracers and a Multicrystal Gamma Camera

Eiji Tadamura, Haruhiro Kitano, Takashi Kudoh, Naoya Hattori, Masayuki Inubushi, Kazunobu Nishimura, Izuru Masuda, Hideo Inada, Ryohei Hosokawa, Ryuji Nohara and Junji Konishi

Departments of Nuclear Medicine and Cardiovascular Surgery, Second and Third Divisions, and Department of Internal Medicine, Kyoto University Faculty of Medicine, Kyoto, Japan

Correspondence: For correspondence or reprints contact: Eiji Tadamura, MD, Department of Nuclear Medicine and Diagnostic Imaging, Kyoto University Faculty of Medicine, Shogoin, Sakyo-ku, Kyoto, 606-01, Japan.

ABSTRACT

The purpose of this study was to validate the accuracy of the assessment of ventricular function by first-pass radionuclide angiography (FPRNA) with 123I myocardial tracers and a multicrystal gammacamera. MethodS: Left ventricular ejection fraction (LVEF) and right ventricular ejection fraction were measured in 69 patients by FPRNA using123I myocardial tracers (126 ± 7 MBq) and 99mTc tracers (541 ± 141 MBq) on a multicrystal gamma camera wfth a high-sensitivity collimator. For 44 patients, ejection fraction values measuredby 123I-FPRNA were compared to those estimated by equilibrium radionuclide angiography (ERNA). Visual wall-motion analysis was also performed to judge clinical acceptability of 123I FPRNAimages for identification of wall-motion abnormality. ResuIts: Mean LVEFs (%) estimated by 123I-FPRNA and by 99mTc FPRNA were 49.6 ± 13.6 and 49.1 ± 14.1, respectively (nonsignificant p value). An excellent correlation was found between LVEFs estimated by 123I-FPRNA and 99mTc-FPRNA (r = 0.96, s.e.e. = 1.9%). Values of LVEF measured by 123I-FPRNA also demonstrated excellent correlation with those measured by ERNA (r = 0.95, s.e.e. = 2.2%). A good correlation was also noted between right ventricular ejection fractions measured by 123I-FPRNA and 99mTc-FPRNA (r = 0.72, s.e.e. = 4.0%). The Spearman rank correlation coefficient between 123I-FPRNA and ERNA wall-motion scores was 0.87 (n =135,p < 0.001). Conclusion: Resting ventricular function can be reliably measured with 123I-FPRNA in combination with a multicrystal gamma camera. This indicates that the assessment of ventricular function is feasible inconjunction with 123I myocardial imaging without an increase in cost or radiation dose to patients.

Key Words: iodine-123 myocardial tracer • first-pass radionuclide angiography • ejection fraction







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1998 by the Society of Nuclear Medicine.